Indicators of disease activity in people with MS treated with DMTs for mild/moderate MS: time to clinical and/or subclinical activityMelanie Peters,David Ellenberger,Fneish Firas,Alexander Stahmann,Tim Friede,Klaus Berger,Peter Flachenecker,Judith Haas,Clemens Warnke,Friedemann Paul,Uwe K. Zettl,Niklas FrahmMULTIPLE SCLEROSIS JOURNAL(2023)引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要